Comparación entre incidencia y factores de riesgo de cáncer oral en diferentes países de América Latina.

Brenda Yuliana Herrera Serna; Edith Lara-Carrillo; Victor Hugo Toral-Rizo; Regiane Cristina do Amaral

doi:10.31052/1853.1180.v24.n2.24336

Autores/as

Brenda Yuliana Herrera Serna Universidad Autónoma de Manizales. Universidad Autónoma del Estado de México
Edith Lara-Carrillo Universidad Autónoma del Estado de México
Victor Hugo Toral-Rizo Universidad Autónoma del Estado de México
Regiane Cristina do Amaral Universidade Federal de Sergipe

DOI:

https://doi.org/10.31052/1853.1180.v24.n2.24336

Palabras clave:

Cancer Oral, Fumar Tabaco, Consumo de Alcohol, Urbanizacíon, Estudio de Correlación

Resumen

Objetivos: Describir las tendencias de la incidencia del cáncer oral según sexos en Americalatina entre 2000 y 2017; y analizar su relación con factores de riesgo. Método: estudio ecológico que describe las tasas y tendencias de incidencia de cáncer oral en Americalatina; y su correlación con el hábito de fumar, consumo de alcohol y urbanización. Resultados:Las tasas más altas se presentan en los hombres (8,01), y mujeres (3,64) de Cuba. Las tendencias son al aumento, sólo Guatemala presenta estancamiento en ambos sexos. Existe correlación positiva entre la incidencia de cáncer oral y el hábito de fumar (r: 0,37), y con el consumo de alcohol (r: 0,60) en los hombres; y negativa con la urbanización en ambos sexos (r: -0,16) (p:<0,01). Conclusión: La incidencia varía entre los países y entre los sexos, con tendencia al aumento. La mayor carga está en los hombres, con correlación con los factores de riesgo.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

Brenda Yuliana Herrera Serna, Universidad Autónoma de Manizales. Universidad Autónoma del Estado de México

Magister en Salud Pública. Estudiante de Posgrado en Universidad Autónoma del Estado de México (México). Investigadora en Universidad Autónoma de Manizales (Colombia).
Edith Lara-Carrillo, Universidad Autónoma del Estado de México

Doctora en Ciencias de la Salud. Directora Facultad de Odontología.
Victor Hugo Toral-Rizo, Universidad Autónoma del Estado de México

Doctor en Patología y Estomatología Oral. Coordinador de Posgrados de la Facultad de Odontología.
Regiane Cristina do Amaral, Universidade Federal de Sergipe

Doctora en Odontología Social. Profesora Adjuntadel Departamento de Odontologia. Universidade Federal de Sergipe.

Referencias

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.

2. Perdomo S, Roa G, Brennan P, Forman D, Sierra M. Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiol. 2016;44S:S43-52.

3. de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP. Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck. 2010;35:357–67.

4. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018;68(6):394–424.

5. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde. Rio de Janeiro, Brasil; 2014.

6. Megwalu UC, Ma Y. Racial disparities in oropharyngeal cancer survival. Oral Oncol. 2017;65:33–7.

7. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva, Switerland; 2018.

8. Leite I. Mortalidade por Câncer de Boca e Faringe em Cidade de Médio Porte na Região Sudeste do Brasil, 1980-2005. Rev Bras Cancerol. 2010;56(1):17–23.

9. Martinez VD, MacAulay CE, Guillaud M, Lam WL, Zhang L, Corbett KK, et al. Targeting of chemoprevention to high-risk potentially malignant oral lesions: Challenges and opportunities. Oral Oncol. 2014;50(12):1123–30.

10. Ferreira Antunes J, Toporcov T, Biazevic M, Boing A, Scully C, Petti S. Joint and independent effects of alcohol drinking and tobacco smoking on oral cancer: a large case-control study. PLoS One. 2013;10(8):e68132.

11. Kim S. Human papilloma virus in oral cancer. J Korean Assoc Oral Maxillofac Surg. 2016;42(6):327–36.

12. Elango K, Suresh A, Erode E, Subhadradevi L, Ravindran H, Iyer S, et al. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12(4):889–96.

13. Khangura R, Sengupta S, Sircar K, Sharma B, Singh S, Rastogi V. HPV involvement in OSCC: Correlation of PCR results with light microscopic features. J Oral Maxillofac Pathol. 2013;17(2):195–200.

14. Patil S, Rao R, Amrutha N, Sanketh D. Analysis of human papilloma virus in oral squamous cell carcinoma using p16: An immunohistochemical study. J Int Soc Prev Community Dent. 2014;4(1):61–6.

15. Blankart C. Does healthcare infrastructure have an impact on delay in diagnosis and survival? Health Policy (New York). 2012;105:128–37.

16. Chang T, Su Y, Lee C. Determinants for Aggressive End-of-Life Care for Oral Cancer Patients A Population-Based Study in an Asian Country. Medicine (Baltimore). 2015;94(4):e460.

17. Macedo da Silva, Bonfante Gisele Machado CJ, Alencar de Souza PE, Gurgel Andrade EI, de Assis Acurcio F, Cherchiglia Leal M. Specific 5-year oral cancer survival and associated factors in cancer outpatients in the Brazilian Unified National Health System. Cad Saúde Pública. 2014;30(5):983–97.

18. Goss P, Lee B, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St L, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013;14(5):391–436.

19. Mariotto A, Yabroff K, Shao Y, Al. E. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117–28.

20. Alforque Thomas A, Timmons A, Molcho M, Pearce A, Gallagher P, Butow P, et al. Quality of life in urban and rural settings: A study of head and neck cancer survivors. Oral Oncol. 2014;50(7):676–82.

21. Wagner K-H, Brath H. A global view on the development of non communicable diseases. Prev Med. 2012;54:S38–41.

22. Mao Y, Yang D, He J, Krasna MJ. Epidemiology of Lung Cancer. Surg Oncol Clin N Am. 2016;25:439–45.

23. Fei X, Chenc W, Zhang S, Liu Q, Zhang Z, Pei Q. The spatio-temporal distribution and risk factors of thyroid cancer during rapid urbanization–A case study in China. Sci Total Env. 2018;630:1436–45.

24. Attar E, Dey S, Hablas A, Seifeldin IA, Ramadan M, Rozek LS, et al. Head and neck cancer in a developing country: A population-based perspective across 8 years. Oral Oncol. 2010;46:591–6.

25. Angkurawaranon C, Jiraporncharoen W, Chenthanakij B, Doyle P, Nitsch D. Urbanization and non-communicable disease in Southeast Asia: a review of current evidence. Public Health. 2014;128:886–95.

26. Organización Panamericana de la Salud. Indicadores de salud: Aspectos conceptuales y operativos (Sección 2) [Internet]. Elaboración y medición de indicadores de salud. 2019 [cited 1BC Mar 30]. p. 1–6. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=14402:health-indicators-conceptual-and-operational-considerations-section-1&Itemid=0&lang=es

27. Washington U of. Institute of Health and Metrics Evaluation. Financing Global Health. 2018.

28. Institute for Health Metrics and Evaluation. Global Data Health Exchange. Global Burden of Disease (GBD). 2018. http://ghdx.healthdata.org

29. World Health Organization. Report on the global tobacco epidemic. Geneva; 2017.

30. World Bank. World Bank Open Data. Indicators. 2018. p. Gender. https://data.worldbank.org

31. World Health Organization, Pan American Health Organization. Informe sobre control del tabaco en la región de las Américas. Washington D.C.; 2016.

32. World Health Organization. Global status report on alcohol and health 2018. Switzerland; 2018.

33. Caribe IL y del, Sociales PE y. El uso de indicadores socioeconómicos en la formulación y evaluación de proyectos sociales. Santiago de Chile; 2001.

34. Antunes J, Waldman E. Trends and spatial distribution of deaths of children aged 12-60 months in São Paulo, Brazil, 1980-98. Bull World Heal Organ. 2002;80(5):391–8.

35. Estrada Perea LM, Peres MA, Boing AF, Ferreira Antunes JL. Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013. Rev Saude Publica. 2018;52(10).

36. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch F, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–99.

37. de Sanjosé S, Diaz M, Castellsague X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence an genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–9.

38. Franceschi S, Castellsague X, Dal Maso L, Smith S, Plummer M, Ngelangel C, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer. 2002;86(5):705–11.

39. Kreimer A, Bhatia R, Messeguer A. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37(6):386–91.

40. Gillison M, Broutian T, Pickard R, Tong Z, Xiao W, L K, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693–703.

41. Ward E, Jemal A, Cokkinides V, Singh G, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2008;54(2):78–93.

42. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–2150.

43. Chatenoud L, Bertuccio P, Bosetti C, Malvezzi M, Levi F, Negri E, et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann Oncol. 2014;25:1843–53.

44. OCDE. OECD Health data: non-medical determinants of Health. OECD health statitics (database). 2014.

45. World Health Organization. WHO Global Report: mortality attributable to tobacco. Geneva; 2012.

46. Reynales-Shigematsu L, Fleischer N, Thrasher J, Zhang Y, Meza R, Cummings K, et al. Effects of tobacco control policies on smoking prevalence and tobacco-attributable deaths in Mexico: the SimSmoke model. Rev Panam Salud Publica. 2015;38:316–325.

47. Gilhodes J, Belot A, Bouvier A-M, Remontet L, Delafosse P, Ligier K, et al. Incidence of major smoking-related cancers: Trends among adults aged 20–44 in France from 1982 to 2012. Cancer Epidemiol. 2015;39:707–13.

48. Monteiro C, Cavalcante T, Moura E, Claro R, Szwarcwald C. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989–2003). Bull World Heal Organ. 2007;85:527–34.

49. Szklo A, de Almeida L, Figueiredo V, Autran M, Malta D, Caixeta R, et al. A snapshot of the striking decrease in cigarette smoking prevalence in Brazil between 1989 and 2008. Prev Med. 2012;54(2):162–7.

50. Abascal W, Esteves E, Goja B, Gonzalez M, Lorenzo A, Sica A, et al. Tobacco control campaign in Uruguay: a population-based trend analysis. Lancet. 2012;380(3):1575–82.

51. Hashibe M, Brennan P, Chuang sc Boscia S, Castellsague X, Chen C. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:541–50.

52. Andersson TM-L, Engholm G, Pukkala E, Stenbeck M, Tryggvadottir L, Storm H, et al. Avoidable cancers in the Nordic countriesdThe impact of alcohol consumption. Eur J Cancer. 2018;103:299e307.

53. Krüger M, Pabst A, Walter C, Sagheb K, Günther C, Blatta S, et al. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: A retrospective analysis of 88 patients and literature overview. J Craniomaxillofac Surg. 2018;42(7):1506–14.

54. Tanaka TI, Alawi F. Human Papillomavirus and Oropharyngeal Cancer. Dent Clin N Am. 2018;62:111–20.